Vascular Access Device Market size was US$ 5.78 Bn in 2023 and is expected to reach US$ 9.40 Bn by 2030 at a CAGR of 7.2% during the forecast period.
The Vascular Access Device Market features major players like Becton, Dickinson, and Company, B. Braun SE, Siemens Healthineers, Baxter International, Teleflex Incorporated, AngioDynamics, Cook Medical, PRODIMED, NIPRO Medical Corporation, Terumo Corporation, Ameco Medical. The industry faces intense rivalry as companies strive to differentiate through product enhancements, improved safety features, and cost efficiency.
In 2023, Becton Dickinson (BD) maintained its leading position in the global vascular access device and accessories market, strengthened by its acquisition of C.R. Bard in 2017. This moves solidified BD's influence across both traditional vascular access devices and their complementary accessories, allowing the company to command leadership across most market segments.
• In November 2023, BD introduced the SiteRite 9 Ultrasound System, featuring advanced image quality, a 15.6-inch touchscreen, and enhanced catheter placement accuracy through the Cue Needle Tracking System and Sherlock 3CG+ Tip Confirmation System. These innovations, along with smart vessel assessment tools, improve clinician workflow and patient care.
3M holds the second-largest market share, deriving substantial revenue from its catheter securement devices and dressings, particularly in Europe. Teleflex, a dominant player in Central Venous Catheters (CVCs) since its 2007 acquisition of Arrow International, also leads in peripherally inserted central catheters (PICCs), midlines, dialysis catheters, and tip-placement devices.
Meanwhile, the vascular access market has reached maturity in certain segments, such as PICCs, with companies investing in new technological advancements. Peripheral intravenous catheters (PIVCs) are also experiencing moderate growth, driven primarily by the rising value of safety PIVCs. Additionally, AngioDynamics streamlined its product offerings in 2024 by selling its PICC and midline portfolios to Spectrum Vascular for $45 million, a move aimed at focusing on high-growth segments and improving gross margins.
Recent Development:
• In 2024, Teleflex introduced the Arrow EZ-IO Intraosseous Access Procedure Tray, a sterile, single-use kit designed to enhance clinician efficiency in challenging vascular access situations.
• In May 2022, Teleflex Incorporated, a global leader in medical technologies, secured Health Canada approval for its MANTA Vascular Closure Device, marking the first biomechanical device designed specifically for closing large bore femoral arterial access sites. The rise in collaborations, acquisitions, and investments in this space is expected to fuel significant market expansion over the coming years.
• By June 2023, Teleflex secured two group purchasing agreements with Premier, Inc., enabling Premier members to access pre-negotiated pricing and terms for Teleflex’s Central Venous and Arterial Vascular Access products.
• A year earlier, in June 2022, Teleflex introduced its Arrow Pressure Injectable Midline Catheter in Australia and New Zealand, expanding its Midline portfolio to better meet clinician needs and enhance patient safety.
• Meanwhile, in January 2022, ICU Medical, Inc. completed the acquisition of Smiths Medical from Smiths Group plc. This deal brought together Smiths Medical's infusion devices, vascular access, and vital care products with ICU Medical's existing operations, creating a leading infusion therapy company with projected combined revenues of $2.5 billion.
• In July 2021, Becton, Dickinson, and Company (BD) further expanded its capabilities with the acquisition of Velano Vascular. Velano's needle-free technology allows for high-quality blood draws from existing peripheral intravenous catheter (PIVC) lines, minimizing the need for multiple needlesticks and improving patient comfort, safety, and satisfaction.
